Q3 2020 SALES: €114.5 MILLION* (UP 14.3%)
Vetoquinol posted sales of €114.5 million for the third quarter of 2020, up 14.3% as reported compared to the same period last year. All Vetoquinol territories posted strong performances with organic growth of 4% in Europe, 16% in the Americas and 29% in Asia Pacific/rest of world. Currency movements curbed Q3 2020 sales by €4.6 million or 4.6%, mainly affecting the Americas territory (Brazil and USA). Third quarter 2020 sales of Essentials products totaled €58.5 million (up 26.8%), driven by 13.6% like-for-like growth as well as the contribution of Profender® and Drontal® products sales (13.2%).
- Public releases
Vetoquinol has been listed on the Euronext Paris stock market since November 16th.
Composition of the bodies of Corporate Management and Governance
Financial information and key figures: annual, half-year and by sector key figures